Zobrazeno 1 - 10
of 173
pro vyhledávání: '"Wedad, Hanna"'
Autor:
Andreas H. Scheel, Frédérique Penault-Llorca, Wedad Hanna, Gustavo Baretton, Peter Middel, Judith Burchhardt, Manfred Hofmann, Bharat Jasani, Josef Rüschoff
Publikováno v:
Diagnostic Pathology, Vol 13, Iss 1, Pp 1-7 (2018)
Abstract Background Detection of HER2/neu receptor overexpression and/or amplification is a prerequisite for efficient anti-HER2 treatment of breast and gastric carcinomas. Immunohistochemistry (IHC) of the HER2 protein is the most common screening t
Externí odkaz:
https://doaj.org/article/b3325c6ae48c49bd9e0ab7a9cb8b79da
Autor:
Eileen Rakovitch, Rinku Sutradhar, Cindy Fong, S. Gu, Lawrence Paszat, Wedad Hanna, Sharon Nofech-Mozes
Publikováno v:
JNCI: Journal of the National Cancer Institute. 113:572-579
Background The inability to identify individuals with ductal carcinoma in situ (DCIS) who are at risk of breast cancer (BC) mortality have hampered efforts to reduce the overtreatment of DCIS. The 21-gene recurrence score (RS) predicts distant metast
Autor:
Ellen Yang, Robert Kozak, Sharon Nofech-Mozes, Elsa Salvant, Ekaterina Olkhov-Mitsel, Elzbieta Slodkowska, Anna Plotkin, Wedad Hanna, Fang-I Lu
Publikováno v:
Journal of Clinical Pathology. :jcp-2022
AimsCystic neutrophilic granulomatous mastitis (CNGM) is a subtype of granulomatous mastitis (GM) associated withCorynebacteriumspp infection. We aimed to analyse the prevalence of Corynebacteria in CNGM and non-CNGM cases.MethodsBreast specimens dia
Autor:
Eileen Rakovitch, Sharon Nofech-Mozes, Wedad Hanna, Fang-I Lu, Carlos Parra-Herran, Elzbieta Slodkowska
Publikováno v:
Modern Pathology. 32:896-915
Ductal carcinoma in situ (DCIS) is a neoplastic proliferation of mammary ductal epithelial cells confined to the ductal-lobular system, and a non-obligate precursor of invasive disease. While there has been a significant increase in the diagnosis of
Publikováno v:
Cancer Research. 79:P4-09
Introduction: Improved individual prediction of 10 yr local recurrence (LR) risk following breast-conserving surgery (BCS) for ductal carcinoma in situ (DCIS) is needed to identify women at low risk, for whom radiotherapy (RT) may be omitted. We hypo
Autor:
Cindy Fong, Eileen Rakovitch, Wedad Hanna, Rinku Sutradhar, Sharon Nofech-Mozes, Nafisha Lalani, S. Gu, Lawrence Paszat
Publikováno v:
Cancer Research. 79:P2-08
Purpose: Ductal Carcinoma in Situ (DCIS) with microinvasion (MI) (< 1mm) includes a spectrum of cases with a single focus of MI and those with multiple foci (2 or more) of MI. The impact of multiple foci of MI on the risks of local recurrence (LR), i
Publikováno v:
Cancer Research. 79:P6-16
Background: The impact of DCIS diagnosis on the development of significant anxiety and depression and on the utilization of breast imaging and breast biopsy procedures, which may reflect fears of breast cancer recurrence, is unknown. We established a
Autor:
Judit Zubovits, Wedad Hanna, Fang-I Lu, Elzbieta Slodkowska, Simon J. Raphael, Sharon Nofech-Mozes, Bin Xu, Carlos Parra-Herran
Publikováno v:
Modern Pathology. 31:1073-1084
Mammary fibroepithelial lesions encompass a wide spectrum of tumors ranging from an indolent fibroadenoma to potentially fatal malignant phyllodes tumor. The criteria used for their classification based on morphological assessment are often challengi
Autor:
Wedad Hanna, Prashant A. Jani, Eileen Rakovitch, Michel Bonin, Bruce Youngson, Cindy Fong, Sandip SenGupta, S. Gu, Lawrence Paszat, Rinku Sutradhar, Alan B. Tuck, Nicola Miller, Nafisha Lalani, Martin C. Chang, Leela Elavathil, Sharon Nofech-Mozes, SJ Done
Publikováno v:
Cancer Research. 78:P4-15
Background: Ductal Carcinoma in Situ (DCIS) is a non-invasive breast cancer often treated with breast-conserving surgery (BCS) with or without radiotherapy (RT). It is unclear if the presence of microinvasion (MI) (invasion ≤1mm) is associated with
Autor:
Sharon Nofech-Mozes, Jacqueline Spayne, Eileen Rakovitch, Harriette J Kahn, Arun Seth, Jean-Phillippe Pignol, Lavina Lickley, Lawrence Paszat, Wedad Hanna M.D. FRCPC
Publikováno v:
Clinical Medicine Insights: Oncology, Vol 2 (2008)
DCIS is a heterogeneous group of non-invasive cancers of the breast characterized by various degrees of differentiation and unpredictable propensity for transformation into invasive carcinoma. We examined the expression and prognostic value of 9 biol
Externí odkaz:
https://doaj.org/article/cc82661479c0441fa3c0598be1a5bf7f